SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,665 | -92.9% | 14,483 | -53.8% | 0.00% | -100.0% |
Q2 2023 | $37,429 | +56.0% | 31,321 | +20.9% | 0.00% | – |
Q3 2020 | $24,000 | +71.4% | 25,907 | -8.9% | 0.00% | – |
Q1 2020 | $14,000 | -22.2% | 28,442 | +110.0% | 0.00% | – |
Q4 2019 | $18,000 | -14.3% | 13,544 | -40.8% | 0.00% | – |
Q3 2019 | $21,000 | – | 22,894 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENDELL JEFFREY L | 4,908,725 | $5,056,000 | 0.66% |
Uniplan Investment Counsel, Inc. | 2,485,327 | $2,559,000 | 0.20% |
Oasis Management Co Ltd. | 850,000 | $876,000 | 0.15% |
AdvisorShares Investments LLC | 470,151 | $484,000 | 0.13% |
1492 Capital Management LLC | 99,819 | $103,000 | 0.07% |
Sovereign Financial Group, Inc. | 75,000 | $77,000 | 0.03% |
ASSET MANAGEMENT CORP /IL/ /ADV | 45,500 | $47,000 | 0.03% |
MAI Capital Management | 1,230,810 | $1,268,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 137,266 | $141,000 | 0.02% |
FORTEM FINANCIAL GROUP, LLC | 20,000 | $21,000 | 0.02% |